<span item_type="fundamental" item_id="a0a4bc74621639542dcf90b10ecdba27" counter_id="ST/US/OSRH" env="prod"></span><span item_type="announcement" item_id="549418554866142081" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 1.136 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.69.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Net Sales</strong>: $1,135,517 for the three months ended June 30, 2025, compared to $881,829 for the same period in 2024, representing a 29% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Net Sales</strong>: $1,896,789 for the six months ended June 30, 2025, compared to $1,792,054 for the same period in 2024, representing a 6% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Gross Profit</strong>: $32,782 for the three months ended June 30, 2025, compared to $232,321 for the same period in 2024, representing an 86% decrease.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Gross Profit</strong>: $201,468 for the six months ended June 30, 2025, compared to $472,122 for the same period in 2024, representing a 57% decrease.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Operating Loss</strong>: -$5,229,177 for the three months ended June 30, 2025, compared to -$3,210,108 for the same period in 2024, representing a 63% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Operating Loss</strong>: -$8,147,004 for the six months ended June 30, 2025, compared to -$6,512,636 for the same period in 2024, representing a 25% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Loss Before Income Taxes</strong>: -$5,225,198 for the three months ended June 30, 2025, compared to -$3,251,115 for the same period in 2024, representing a 61% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Loss Before Income Taxes</strong>: -$16,618,012 for the six months ended June 30, 2025, compared to -$6,606,477 for the same period in 2024, representing a 152% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: -$546,678 for the six months ended June 30, 2025, compared to -$981,991 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Net Cash Provided by Investing Activities</strong>: $657,167 for the six months ended June 30, 2025, compared to $446,192 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Net Cash Provided by Financing Activities</strong>: $1,040,863 for the six months ended June 30, 2025, compared to $524,848 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Accumulated Deficit</strong>: -$30,175,318 as of June 30, 2025, compared to -$19,173,063 as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Debt Ratio</strong>: 3.2% as of June 30, 2025, compared to 1.4% as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li><strong>Tokenization Initiative</strong>: OSRH announced a strategic roadmap for tokenizing its equity in partnership with BCM Europe AG, aiming to leverage blockchain-based finance to enhance capital raising opportunities and increase liquidity.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li><li><strong>Acquisition of Woori IO</strong>: OSRH signed a term sheet to acquire Woori IO, a leader in noninvasive glucose monitoring technology, to strengthen its presence in the healthcare and medical technology sectors.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h4>Non-Core Business</h4><ul><li><strong>Equity Line of Credit (ELOC)</strong>: OSRH entered into an ELOC agreement providing up to $80 million in potential capital, with $741,937 raised through June 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul><h4>Priority</h4><ul><li><strong>R&amp;D Expenses</strong>: OSRH expects to incur R&amp;D expenses of $2.5 million to $3.0 million per quarter beginning in the second half of 2025, potentially increasing to $5.0 million to $6.0 million per quarter.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1840425/000121390025076461/ea0252808-10q_osrholdings.htm"></span></li></ul>

OSR | 10-Q: FY2025 Q2 Revenue: USD 1.136 M